The lymphatic route. VIII. Distribution and plasma clearance of recombinant human interleukin-2 after SC administration with albumin in patients
Biotherapy · 1993
DOI: 10.1007/bf01877388 ↗At a glance
Journal article in Biotherapy, 1993. Written by V Bocci and 4 co-authors. Institution: Institute of General Physiology, University of Siena, Italy. Cited 2 times so far (Crossref); 18 references.
Abstract (original language)
It has been postulated that favouring the absorption of interleukin-2 via lymphatics rather than venous capillaries after subcutaneous administration may improve its therapeutic index. We have now evaluated in 12 cancer patients the plasma pharmacokinetic of interleukin-2 either dissolved in water or in 20% albumin solution with an internal cross-over after at least three days. Our data show that when albumin is present, the plasma concentrations of interleukin-2 versus time is increased and swelling at the injection sites is reduced. It remains to be seen whether efficacy improves during a prolonged treatment.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Institute of General Physiology, University of Siena, Italy.
Cite
APA
Bocci, V., Carraro, F., Zeuli, M., Naldini, A., & Calabresi, F. (1993). The lymphatic route. VIII. Distribution and plasma clearance of recombinant human interleukin-2 after SC administration with albumin in patients. Biotherapy. https://doi.org/10.1007/bf01877388
Vancouver
Bocci V, Carraro F, Zeuli M, Naldini A, Calabresi F. The lymphatic route. VIII. Distribution and plasma clearance of recombinant human interleukin-2 after SC administration with albumin in patients. Biotherapy. 1993. doi:10.1007/bf01877388
BibTeX
@article{Bocci1993,
author = {Bocci, V and Carraro, F and Zeuli, M and Naldini, A and Calabresi, F},
title = {The lymphatic route. VIII. Distribution and plasma clearance of recombinant human interleukin-2 after SC administration with albumin in patients},
journal = {Biotherapy},
year = {1993},
doi = {10.1007/bf01877388}
}
EUVIMED